WebJul 25, 2024 · Foster, Curosurf and Clenil are the key brand name drugs to treat problems of the respiratory area, developed and marketed by the Italian pharmaceutical company … WebChiesi group is fully determined to serve the ailing humanity suffering from asthma and COPD (Chronic obstructive pulmonary disease). Asthma and COPD are characterized by a reduction in the respiratory flow although they are driven by a different pathophysiological pathway. Asthma is one of the major non-communicable diseases.
Chiesi - Respiratory diseases
WebApr 12, 2024 · Amryt is a global commercial-stage biopharmaceutical company focused on acquiring, developing, and commercializing innovative treatments to help improve the lives of patients with rare and orphan diseases. Amryt comprises a strong and growing portfolio of commercial and development assets. For more information on Amryt, including products ... WebThe Group’s historical products, focussing on the respiratory and cardiovascular therapeutic areas, continue to be well-established, and new products for neonatal … au 通信障害 c メール
Chiesi USA
WebChiesi USA is predominantly focused on the key areas of respiratory, neonatology, and special care. RESPIRATORY The respiratory area is the hub of Research & … WebChiesi Group is closely monitoring the COVID-19 outbreak and is acting in order to make the health and wellbeing of patients and employees a priority. Dedicated teams across our network are taking measures to protect the continuous supply of our medicines in all countries and implemented strict guidelines to ensure the safety of all employees across … WebOct 18, 2024 · Chiesi is an international, research-focused biopharmaceuticals group that develops and markets innovative therapeutic solutions in respiratory health, rare diseases, and specialty care. au 通信 障害 line は できる